| |
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 |
53.29 |
| |
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway |
52.71 |
| |
circRNA-sequencing |
41.15 |
| |
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) |
40.8 |
| |
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] |
39.42 |
| |
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation |
39.42 |
| |
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells |
33.98 |
| |
SUV420H2 knockdown in PANC-1 |
33.74 |
| |
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq |
32.39 |
| |
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells |
30.36 |
| |
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner |
28.81 |
| |
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors |
28.69 |
| |
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering |
27.1 |
| |
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism |
26.43 |
| |
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen |
26.4 |
| |
RNA-seq of YB5 and MCF7 treated with different doses of decitabine |
26.05 |
| |
TCF7L1 knockdown in pancreatic cancer |
24.26 |
| |
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) |
23.56 |
| |
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells |
23.32 |
| |
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids |
23.12 |
| |
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors |
22.97 |
| |
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors |
22.97 |
| |
Dtx3L and Androgen Signaling in Prostate Cancer |
22.67 |
| |
G-quadruplex structures mark human regulatory chromatin |
22.3 |
| |
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 |
22.04 |
| |
Survival of pancreatic cancer cells lacking KRAS function |
21.83 |
| |
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins |
21.02 |
| |
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions |
20.88 |
| |
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis |
20.33 |
| |
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] |
20.3 |
| |
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells |
20.3 |
| |
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] |
19.43 |
| |
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination |
19.34 |
| |
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell |
19.23 |
| |
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation |
18.81 |
| |
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique |
18.76 |
| |
Adipocyte-derived lipids mediate melanoma progression via FATP proteins |
18.6 |
| |
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] |
18.44 |
| |
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer |
18.44 |
| |
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile |
18.3 |
| |
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells |
18.04 |
| |
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells |
17.81 |
| |
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control |
17.34 |
| |
Toxoplasma gondii infection of human retinal pigment epithelial cells |
17.2 |
| |
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells |
17.18 |
| |
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator |
16.96 |
| |
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] |
16.96 |
| |
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells |
16.93 |
| |
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors |
16.91 |
| |
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media |
16.84 |
| |
Intrahepatic MAIT cell gene expression revealed by RNA-seq |
16.68 |
| |
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy |
16.28 |
| |
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption |
16.24 |
| |
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression |
16.22 |
| |
Paxillin regulates genomic networks in prostate cancer [C4-2] |
16.14 |
| |
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. |
16.14 |
| |
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. |
15.92 |
| |
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling |
15.86 |
| |
Identification of differentially expressed genes between senescence and senescence bypass cells |
15.85 |
| |
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways |
15.84 |
| |
UBC9 knockdown in bladder cancer T24 cell lines |
15.82 |
| |
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction |
15.8 |
| |
IL-33 activates tumor stroma to promote intestinal polyposis |
15.56 |
| |
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis |
15.3 |
| |
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] |
15.3 |
| |
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell |
15.03 |
| |
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA |
14.97 |
| |
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA |
14.92 |
| |
hTERT promotes cell adhesion and migration independent of telomerase activity |
14.49 |
| |
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. |
14.47 |
| |
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. |
14.47 |
| |
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] |
14.38 |
| |
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes |
14.37 |
| |
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. |
14.33 |
| |
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes |
14.17 |
| |
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] |
14.16 |
| |
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition |
14.16 |
| |
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO |
14.09 |
| |
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway |
13.93 |
| |
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] |
13.74 |
| |
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) |
13.7 |
| |
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability |
13.7 |
| |
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] |
13.48 |
| |
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 |
13.48 |
| |
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis |
13.37 |
| |
PGE2 mediated gene expression changes in human cervical stromal cells |
13.33 |
| |
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells |
13.29 |
| |
Transcriptome analysis of virus infected tissues |
13.29 |
| |
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. |
13.28 |
| |
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin |
13.25 |
| |
Nucleoporin-mediated regulation of cell identity genes |
13.18 |
| |
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury |
13.11 |
| |
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] |
13.11 |
| |
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting |
12.99 |
| |
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] |
12.99 |
| |
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells |
12.97 |
| |
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines |
12.8 |
| |
High-efficiency RNA-based reprogramming of human primary fibroblasts |
12.8 |
| |
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] |
12.72 |
| |
Effects of Belinostat and Dexamethasone treatment of A549 gene expression |
12.62 |
| |
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells |
12.6 |
| |
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment |
12.55 |
| |
A549 cells and MSR-A549 cells |
12.55 |
| |
Transcriptome of activated human and mouse MAIT cells |
12.49 |
| |
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts |
12.46 |
| |
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 |
12.46 |
| |
RNA-seq of YB5 cells treated with Proscillaridin A |
12.45 |
| |
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors |
12.44 |
| |
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. |
12.41 |
| |
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 |
12.35 |
| |
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) |
12.17 |
| |
Control of prostate tumour growth by the long non-coding RNA GHSROS |
12.1 |
| |
CHD1 regulates cell fate determination by activation of differentiation-induced genes |
12.07 |
| |
RNA-seq analysis of uveal melanoma cells treated with FR900359 |
12.07 |
| |
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer |
11.86 |
| |
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors |
11.76 |
| |
Transcriptomic analysis of LSD1 |
11.66 |
| |
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay |
11.62 |
| |
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM |
11.55 |
| |
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO |
11.55 |
| |
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] |
11.55 |
| |
Chromatin-informed inference of transcriptional programs in gynecologic cancers |
11.55 |
| |
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress |
11.37 |
| |
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] |
11.37 |
| |
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx |
11.34 |
| |
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] |
11.26 |
| |
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases |
11.26 |
| |
Genetic-to-epigenetic Therapy for Pancreatic Cancer |
11.08 |
| |
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients |
11.06 |
| |
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia |
10.99 |
| |
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I |
10.96 |
| |
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells |
10.95 |
| |
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production |
10.95 |
| |
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells |
10.94 |
| |
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic |
10.89 |
| |
An siRNA screen identifies CHD4 as a target for epigenetic therapy |
10.88 |
| |
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 |
10.75 |
| |
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] |
10.75 |
| |
MicroRNA targetome analysis during HCMV infection |
10.59 |
| |
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells |
10.57 |
| |
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) |
10.53 |
| |
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST |
10.45 |
| |
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency |
10.36 |
| |
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] |
10.36 |
| |
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation |
10.27 |
| |
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells |
10.27 |
| |
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] |
10.18 |
| |
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia |
10.18 |
| |
Investigation about fibroblasts of different origins in culture |
10.13 |
| |
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] |
10.13 |
| |
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes |
10.07 |
| |
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines |
10.04 |
| |
mRNA sequencing of oropharyngeal cancer cell lines |
10.02 |
| |
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) |
10.01 |
| |
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer |
9.98 |
| |
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer |
9.92 |
| |
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] |
9.91 |
| |
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling |
9.91 |
| |
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma |
9.86 |
| |
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] |
9.82 |
| |
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator |
9.82 |
| |
A sister of NANOG regulates genes expressed in pre-implantation human development |
9.8 |
| |
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] |
9.77 |
| |
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders |
9.77 |
| |
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines |
9.77 |
| |
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] |
9.77 |
| |
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 |
9.77 |
| |
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 |
9.69 |
| |
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 |
9.68 |
| |
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression |
9.68 |
| |
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites |
9.64 |
| |
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion |
9.62 |
| |
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis |
9.6 |
| |
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors |
9.56 |
| |
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] |
9.56 |
| |
EGR1-controlled transcriptome of T HESCs |
9.55 |
| |
Gene expression profile of LMSU gastric cancer cell p53 KO and KD |
9.49 |
| |
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells |
9.39 |
| |
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis |
9.36 |
| |
The evolution of N6-methyladenosine in primates |
9.35 |
| |
BAF controls genome accessibility |
9.27 |
| |
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors |
9.26 |
| |
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors |
9.26 |
| |
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component |
9.25 |
| |
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling |
9.22 |
| |
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis |
9.22 |
| |
Ro60-knockout cells |
9.21 |
| |
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes |
9.16 |
| |
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma |
9.15 |
| |
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated |
9.14 |
| |
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex |
9.14 |
| |
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition |
9.13 |
| |
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast |
9.08 |
| |
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast |
9.08 |
| |
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming |
9.07 |
| |
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function |
9.07 |
| |
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] |
9.07 |
| |
Lysine benzoylation is a novel histone mark [RNA-seq] |
9.01 |
| |
Lysine benzoylation is a novel histone mark |
9.01 |
| |
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors |
8.9 |
| |
Disruption of the exocyst induces podocyte loss and dysfunction |
8.86 |
| |
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells |
8.83 |
| |
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge |
8.76 |
| |
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion |
8.73 |
| |
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence |
8.73 |
| |
Evolution of a transcriptional regulator from a transmembrane nucleoporin |
8.71 |
| |
RNA-seq in HepG2 and IMR90 cells |
8.71 |
| |
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients |
8.68 |
| |
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes |
8.68 |
| |
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] |
8.63 |
| |
Nuclear Parkin Regulates Transcriptional Response during Hypoxia |
8.61 |
| |
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin |
8.59 |
| |
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression |
8.53 |
| |
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] |
8.53 |
| |
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation |
8.51 |
| |
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] |
8.51 |
| |
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML |
8.47 |
| |
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib |
8.46 |
| |
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers |
8.4 |
| |
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases |
8.37 |
| |
Transcriptomic profiling of human peripheral blood-derived mast cells |
8.37 |
| |
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes |
8.36 |
| |
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 |
8.36 |
| |
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] |
8.35 |
| |
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) |
8.33 |
| |
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone |
8.29 |
| |
X-Ray induced DNA-Hydroxymethylation changes |
8.28 |
| |
RNA seq comparison between scrambled and shGRP78 cells |
8.25 |
| |
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism |
8.18 |
| |
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration |
8.13 |
| |
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer |
8.12 |
| |
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors |
8.02 |
| |
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] |
8.02 |
| |
Regulation of protein translation during mitosis |
7.94 |
| |
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer |
7.92 |
| |
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis |
7.85 |
| |
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. |
7.85 |
| |
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes |
7.85 |
| |
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] |
7.85 |
| |
Unraveling cis-regulatory elements by mapping structural changes in mRNAs |
7.84 |
| |
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming |
7.79 |
| |
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) |
7.79 |
| |
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) |
7.78 |
| |
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs |
7.78 |
| |
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) |
7.72 |
| |
RNA-seq of shEZH2 cells |
7.72 |
| |
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia |
7.72 |
| |
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines |
7.66 |
| |
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer |
7.63 |
| |
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 |
7.56 |
| |
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) |
7.53 |
| |
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells |
7.53 |
| |
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor |
7.48 |
| |
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes |
7.47 |
| |
The cytokine environment influence on human skin-derived T cells |
7.46 |
| |
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts |
7.43 |
| |
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes |
7.35 |
| |
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not |
7.35 |
| |
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes |
7.33 |
| |
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells |
7.32 |
| |
MRTF activates TEAD-YAP target gene expression |
7.31 |
| |
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity |
7.25 |
| |
High level DNA repair gene expression in human ES cells |
7.19 |
| |
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 |
7.13 |
| |
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas |
7.1 |
| |
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq |
7.05 |
| |
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression |
7.04 |
| |
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) |
7.03 |
| |
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] |
7.01 |
| |
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] |
6.96 |
| |
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression |
6.96 |
| |
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation |
6.93 |
| |
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. |
6.92 |
| |
Downregulation of LATS kinases alters p53 to promote cell migration |
6.92 |
| |
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] |
6.9 |
| |
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas |
6.9 |
| |
Differential gene expression in Jagged1 treated human dental pulp cells. |
6.89 |
| |
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines |
6.88 |
| |
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 |
6.87 |
| |
HNRNPL and its RNA Targets in Prostate Cancer |
6.85 |
| |
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells |
6.85 |
| |
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks |
6.84 |
| |
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation |
6.84 |
| |
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process |
6.81 |
| |
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) |
6.81 |
| |
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms |
6.8 |
| |
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner |
6.77 |
| |
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts |
6.76 |
| |
Transcriptome of human keratinocytes with or without HPV16 oncogene expression |
6.75 |
| |
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients |
6.74 |
| |
Seletive inhibition of CDK9 in DLBCL cell lines |
6.65 |
| |
Generation of trichogenic adipose-derived stem cells by expression of three factors |
6.64 |
| |
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts |
6.63 |
| |
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 |
6.53 |
| |
GATA3-mediated chromatin reprogramming in breast cancer cells |
6.53 |
| |
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response |
6.5 |
| |
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells |
6.48 |
| |
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization |
6.48 |
| |
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells |
6.48 |
| |
Generation of KRAS signatures using immortalized isogenic lung cells. |
6.43 |
| |
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] |
6.35 |
| |
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation |
6.35 |
| |
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies |
6.34 |
| |
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs |
6.27 |
| |
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) |
6.23 |
| |
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism |
6.19 |
| |
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma |
6.18 |
| |
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] |
6.18 |
| |
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer |
6.13 |
| |
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart |
6.08 |
| |
Genome-wide chromatin analysis of Ewing sarcoma |
6.03 |
| |
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) |
6.03 |
| |
mRNA differential expression analysis in a human ex vivo model of chronic wounds |
5.99 |
| |
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization |
5.99 |
| |
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies |
5.97 |
| |
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance |
5.92 |
| |
Aortic Valve Tissue: Stenosis vs. Sclerosis |
5.86 |
| |
Gene expression in GBM with Cav3.2 inhibition |
5.85 |
| |
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer |
5.85 |
| |
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression |
5.82 |
| |
Role of COP1 on MAP kinase transcriptional output in melanoma |
5.77 |
| |
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment |
5.65 |
| |
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration |
5.62 |
| |
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. |
5.61 |
| |
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) |
5.6 |
| |
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate |
5.46 |
| |
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] |
5.46 |
| |
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells |
5.42 |
| |
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes |
5.4 |
| |
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown |
5.38 |
| |
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) |
5.38 |
| |
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) |
5.38 |
| |
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs |
5.28 |
| |
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells |
5.28 |
| |
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) |
5.28 |
| |
Redifferentiation of expanded human islet β cells by inhibition of ARX |
5.26 |
| |
Modeling Familial Cancer with iPSC Approaches |
5.23 |
| |
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles |
5.14 |
| |
Real-time observation of light-controlled transcription in living cells |
5.14 |
| |
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. |
5.14 |
| |
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA |
5.14 |
| |
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. |
5.14 |
| |
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation |
5.08 |
| |
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) |
4.97 |
| |
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes |
4.97 |
| |
Effect of drugs on transcriptomic profiles |
4.93 |
| |
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer |
4.86 |
| |
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] |
4.86 |
| |
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing |
4.8 |
| |
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations |
4.79 |
| |
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] |
4.79 |
| |
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data |
4.76 |
| |
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells |
4.75 |
| |
Gene expression profile in breast cancer cells |
4.75 |
| |
iPSC-Derived Cholangiocytes |
4.75 |
| |
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome |
4.74 |
| |
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] |
4.72 |
| |
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes |
4.7 |
| |
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers |
4.65 |
| |
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] |
4.65 |
| |
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer |
4.57 |
| |
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications |
4.53 |
| |
RNA sequencing analysis of selumetinib-resistant CRC cells lines |
4.51 |
| |
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures |
4.5 |
| |
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] |
4.5 |
| |
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease |
4.45 |
| |
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) |
4.45 |
| |
RNA sequencing analysis of triple cytokine-captured human CD4 T cells |
4.43 |
| |
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] |
4.43 |
| |
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division |
4.41 |
| |
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) |
4.38 |
| |
Effect of nuclear IL-33 on gene expression |
4.37 |
| |
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma |
4.35 |
| |
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] |
4.35 |
| |
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells |
4.35 |
| |
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells |
4.28 |
| |
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation |
4.2 |
| |
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression |
4.09 |
| |
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells |
3.98 |
| |
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells |
3.97 |
| |
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy |
3.97 |
| |
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] |
3.91 |
| |
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition |
3.91 |
| |
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs |
3.87 |
| |
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers |
3.85 |
| |
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells |
3.85 |
| |
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines |
3.85 |
| |
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression |
3.8 |
| |
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions |
3.71 |
| |
Mapping interactions for the TNIP2 hub protein |
3.71 |
| |
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK |
3.48 |
| |
6mer seed toxicity in viral microRNAs |
3.46 |
| |
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] |
3.42 |
| |
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription |
3.42 |
| |
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] |
3.42 |
| |
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice |
3.4 |
| |
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 |
3.37 |
| |
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq |
3.36 |
| |
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops |
3.36 |
| |
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis |
3.34 |
| |
Transcriptional profiling of CD45RO+CD57+CD4+ T cells |
3.31 |
| |
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer |
3.3 |
| |
Transcriptomic analysis of ERR alpha orphan nuclear receptor |
3.28 |
| |
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment |
3.27 |
| |
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants |
3.24 |
| |
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency |
3.23 |
| |
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] |
3.23 |
| |
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures |
3.15 |
| |
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] |
3.15 |
| |
UV_24h_GRO-Seq |
3.01 |
| |
Gene expression changes in human melanoma cell lines compared to primary melanocytes |
2.97 |
| |
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection |
2.84 |
| |
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells |
2.83 |
| |
MHC Transcriptomic landscape at haplotype-specific resolution |
2.65 |
| |
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer |
2.65 |
| |
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) |
2.63 |
| |
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity |
2.62 |
| |
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II |
2.61 |
| |
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] |
2.58 |
| |
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 |
2.54 |
| |
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses |
2.51 |
| |
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) |
2.47 |
| |
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome |
2.47 |
| |
A prostate cancer chromatin interaction map |
2.41 |
| |
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] |
2.4 |
| |
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs |
2.38 |
| |
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP |
2.34 |
| |
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation |
2.3 |
| |
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells |
2.29 |
| |
Transcriptome of EBV-infected gastric cancer cell lines |
2.25 |
| |
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG |
2.14 |
| |
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] |
2.14 |
| |
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism |
2.12 |
| |
Metabolism as an early predictor of DPSCs aging |
2.05 |
| |
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines |
2.0 |
| |
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing |
1.91 |
| |
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown |
1.88 |
| |
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown |
1.88 |
| |
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells |
1.88 |
| |
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML |
1.86 |
| |
Persistence of stem cell metabolism in cancers as a failure of differentiation |
1.76 |
| |
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation |
1.72 |
| |
Effects of transcription on genome - nuclear lamina interactions |
1.65 |
| |
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data |
1.65 |
| |
RNA splicing alteration on glioblastoma and normal neural stem cells |
1.61 |
| |
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes |
1.56 |
| |
Fusion discovery in breast cancer cell line |
1.56 |
| |
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant |
1.46 |
| |
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] |
1.44 |
| |
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. |
1.44 |
| |
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent |
1.43 |
| |
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) |
1.43 |
| |
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence |
1.42 |
| |
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder |
1.35 |
| |
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify |
1.35 |
| |
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism |
1.33 |
| |
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] |
1.32 |
| |
HNRNPM-regulated splicing dependencies in prostate cancer |
1.32 |
| |
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators |
1.27 |
| |
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] |
1.19 |
| |
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells |
1.18 |
| |
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) |
1.18 |
| |
Characterization of human ILC2 subsets |
1.15 |
| |
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells |
1.14 |
| |
Finding missing proteins from epigenetically manipulated human cells |
1.13 |
| |
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans |
1.12 |
| |
The circadian transcriptional landscape in primary human mammary epithelial cells |
1.11 |
| |
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes |
1.11 |
| |
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels |
1.04 |
| |
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance |
1.02 |
| |
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] |
0.97 |
| |
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL |
0.97 |
| |
Transposon-based construction of strand-specific RNA-seq libraries |
0.91 |
| |
FOXP2's impact on the primate transcriptome |
0.88 |
| |
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype |
0.86 |
| |
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] |
0.86 |
| |
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] |
0.8 |
| |
Differences in miRNA Detection Levels are Technology and Sequence Dependent |
0.8 |
| |
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma |
0.8 |
| |
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors |
0.77 |
| |
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells |
0.76 |
| |
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. |
0.76 |
| |
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile |
0.68 |
| |
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. |
0.68 |
| |
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line |
0.64 |
| |
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] |
0.44 |
| |
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors |
0.43 |
| |
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. |
0.34 |
| |
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) |
0.32 |
| |
MAIT cell RNA sequencing |
0.17 |
| |
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] |
0.14 |
| |
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer |
0.14 |
| |
CDK4/6 inhibitor resistance in prostate cancer |
0.11 |
| |
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth |
0.09 |
| |
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells |
0.09 |
| |
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines |
0.07 |
| |
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines |
0.05 |
| |
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 |
0.05 |
| |
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] |
0.04 |
| |
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets |
0.01 |